Revance Therapeutics Inc (RVNC)

[vinmantoo]

The major problem here is a lack of efficacy of the real world product. At double the [unit]dose the real world duration (time between treatment) we are seeing in patients is around 4 months, occasionally 4.5 months. Nowhere near the 6 months originally advertised/marketed.The major problem is that with equivalent dosing (1:1 Botox Units or 1:3 dysport units) we are seeing 2-3 months duration (time between treatments) with Daxxify, which is actually shorter than with Botox and Dysport.

You are lying. Funny how you disregard the stellar clinical trial data that is available for everyone to examine and expect us to trust the word of an anonymous message board posters who just arrived and throws out unverifiable "real world" data as their "proof". The idea of using "equivalent" units as a metric shows you are here to spread disinformation. You sound like the short on the yahoo board.

Lastly, a key fact that everyone overlooks is that over a decade ago Allergan (before it became the devil company in our industry) looked at adding stabilizing peptides to onabotulinum (Botox) with the idea that it would increase duration. They found that while it increased duration slightly it was not a significant enough increase in duration to proceed with wide scale trials.

Bbbwwwaaa hhhaaaaa! So Allergan failed so that means everyone must fail. Ooops, you once again are ignoring the stellar clinical trial data which shows Daxxify does last median of twice as long.So what was the composition of their peptide stabilizer as compared to RVNC's. Why don't you provide us the Allergan clinical trial data so we can compare it to RNVC's data?